Colorcon Opens Major Facility in India
PTSM: Pharmaceutical Technology Sourcing and Management
Colorcon invests in significant expansion of its South Asia production facility.
Colorcon announced that it has completed a major expansion of its South Asia production facility in Verna, Goa, India. The Goa site operates under schedule M of the Indian FDA and IPEC guidelines, with Colorcon accredited to the latest ISO 9001 standard.
Colorcon provides film coatings, modified-release technologies, functional excipients and tablet-design services to the pharmaceutical industry. The Goa plant is one of six Colorcon manufacturing plants dedicated to film coatings. These plants are strategically located close to key customer centers in India, China, Europe, North America and Japan.
Subodh Priolkar, regional managing director for South Asia, said during the opening event that the investment would enable Colorcon to continue to meet the needs of its customers through security of supply and short lead times.
Martti Hedman, CEO of Colorcon, added that India is one of the fastest growing pharmaceutical markets and is also the most important production cluster of generic medicines for global markets. “Colorcon is investing heavily in India to support its customers during both development and manufacture,” Hedman said. “Speed to market, cost to produce and consistently high product quality are our customers’ strategic objectives.”
Source: Colorcon
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
